Tuberculosis Screening Gaps Persist in New DMARD Users

Substantial patient safety gaps regarding latent tuberculosis screening persist among new users of biologic or targeted synthetic DMARDs, suggested a nationwide cohort study.

Related Keywords

California ,United States ,San Francisco ,Erict Roberts , ,University Of California ,Arthritis Care Research ,Hispanic White ,Arthritis Care ,Biologic Therapy ,Iologics ,Tuberculosis Tb ,Disease Modifying Antirheumatic Drugs ,Sdmards ,Simard ,Rheumatoid Arthritis Ra ,Heumatoid Arthritis Ra ,Arthritis ,Oint Inflammation ,Medicare ,Preventive Screening ,Screening ,Patient Safety ,A Scan Biometry ,A Scan Ultrasound Biometry ,Ea Scan ,Clinical Guidelines ,Guidelines ,